サマリー

肺炎球菌ワクチンの世界市場 2023-2027
肺炎球菌ワクチン市場は、2022年から2027年にかけて28億2053万米ドルの成長が予測され、予測期間中のCAGRは5.81%で加速すると予測されます。当レポートでは、肺炎球菌ワクチン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、発展途上国における政府による予防接種プログラムの拡大、ワクチン接種に関する意識の高まり、肺炎球菌疾患の罹患率の増加によって牽引されています。
Technavioの肺炎球菌ワクチン市場は以下のようにセグメント化されています：
タイプ別
- 肺炎球菌結合型ワクチン
- 肺炎球菌多糖体ワクチン
流通経路別
- 非政府組織
- 政府当局
- 流通パートナー企業
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、ワクチン技術の進歩が今後数年間の肺炎球菌ワクチン市場の成長を促進する主な要因の一つであると指摘しています。また、新規肺炎球菌ワクチンの出現や混合ワクチンの出現は、市場の大きな需要につながるでしょう。
肺炎球菌ワクチン市場に関するレポートは以下の分野をカバーしています：
- 肺炎球菌ワクチン市場規模
- 肺炎球菌ワクチン市場予測
- 肺炎球菌ワクチン市場産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させることを目的としており、これに沿って本レポートでは、アステラス製薬、CSL Ltd、グラクソ・スミスクラインPlc、Merck and Co.Inc.、Panacea Biotec Ltd.、Pfizer Inc.、Sanofi、Serum Institute of India Pvt. Ltd.、Shenzhen Kangtai Biological Products Co.Ltd.、Sinovac Biotech Ltd.、SK Inc.、Biological E. Ltd.、Inventprise Inc.、Petrovax、Vaxcyte Inc.、Walvax Biotechnology Co.Ltd.である。また、肺炎球菌ワクチン市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/pneumococcal-vaccine-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global pneumococcal vaccine market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global pneumococcal vaccine market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Pneumococcal conjugate vaccine - Market size and forecast 2022-2027
o Exhibit 34: Chart on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
o 6.4 Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027
o Exhibit 38: Chart on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Non-governmental organizations - Market size and forecast 2022-2027
o Exhibit 48: Chart on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
o 7.4 Government authorities - Market size and forecast 2022-2027
o Exhibit 52: Chart on Government authorities - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Government authorities - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Government authorities - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Government authorities - Year-over-year growth 2022-2027 (%)
o 7.5 Distribution partner companies - Market size and forecast 2022-2027
o Exhibit 56: Chart on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Distribution partner companies - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Distribution partner companies - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ million)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Astellas Pharma Inc.
o Exhibit 111: Astellas Pharma Inc. - Overview
o Exhibit 112: Astellas Pharma Inc. - Product / Service
o Exhibit 113: Astellas Pharma Inc. - Key news
o Exhibit 114: Astellas Pharma Inc. - Key offerings
o 12.4 Biological E. Ltd.
o Exhibit 115: Biological E. Ltd. - Overview
o Exhibit 116: Biological E. Ltd. - Product / Service
o Exhibit 117: Biological E. Ltd. - Key offerings
o 12.5 CSL Ltd.
o Exhibit 118: CSL Ltd. - Overview
o Exhibit 119: CSL Ltd. - Business segments
o Exhibit 120: CSL Ltd. - Key offerings
o Exhibit 121: CSL Ltd. - Segment focus
o 12.6 GlaxoSmithKline Plc
o Exhibit 122: GlaxoSmithKline Plc - Overview
o Exhibit 123: GlaxoSmithKline Plc - Business segments
o Exhibit 124: GlaxoSmithKline Plc - Key news
o Exhibit 125: GlaxoSmithKline Plc - Key offerings
o Exhibit 126: GlaxoSmithKline Plc - Segment focus
o 12.7 Merck and Co. Inc.
o Exhibit 127: Merck and Co. Inc. - Overview
o Exhibit 128: Merck and Co. Inc. - Business segments
o Exhibit 129: Merck and Co. Inc. - Key news
o Exhibit 130: Merck and Co. Inc. - Key offerings
o Exhibit 131: Merck and Co. Inc. - Segment focus
o 12.8 Panacea Biotec Ltd.
o Exhibit 132: Panacea Biotec Ltd. - Overview
o Exhibit 133: Panacea Biotec Ltd. - Product / Service
o Exhibit 134: Panacea Biotec Ltd. - Key offerings
o 12.9 Petrovax
o Exhibit 135: Petrovax - Overview
o Exhibit 136: Petrovax - Product / Service
o Exhibit 137: Petrovax - Key offerings
o 12.10 Pfizer Inc.
o Exhibit 138: Pfizer Inc. - Overview
o Exhibit 139: Pfizer Inc. - Product / Service
o Exhibit 140: Pfizer Inc. - Key news
o Exhibit 141: Pfizer Inc. - Key offerings
o 12.11 Sanofi
o Exhibit 142: Sanofi - Overview
o Exhibit 143: Sanofi - Business segments
o Exhibit 144: Sanofi - Key news
o Exhibit 145: Sanofi - Key offerings
o Exhibit 146: Sanofi - Segment focus
o 12.12 Serum Institute of India Pvt. Ltd.
o Exhibit 147: Serum Institute of India Pvt. Ltd. - Overview
o Exhibit 148: Serum Institute of India Pvt. Ltd. - Product / Service
o Exhibit 149: Serum Institute of India Pvt. Ltd. - Key offerings
o 12.13 Shenzhen Kangtai Biological Products Co. Ltd.
o Exhibit 150: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
o Exhibit 151: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
o Exhibit 152: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
o 12.14 Sinovac Biotech Ltd.
o Exhibit 153: Sinovac Biotech Ltd. - Overview
o Exhibit 154: Sinovac Biotech Ltd. - Product / Service
o Exhibit 155: Sinovac Biotech Ltd. - Key offerings
o 12.15 SK Inc.
o Exhibit 156: SK Inc. - Overview
o Exhibit 157: SK Inc. - Product / Service
o Exhibit 158: SK Inc. - Key offerings
o 12.16 Vaxcyte Inc.
o Exhibit 159: Vaxcyte Inc. - Overview
o Exhibit 160: Vaxcyte Inc. - Product / Service
o Exhibit 161: Vaxcyte Inc. - Key offerings
o 12.17 Walvax Biotechnology Co. Ltd.
o Exhibit 162: Walvax Biotechnology Co. Ltd. - Overview
o Exhibit 163: Walvax Biotechnology Co. Ltd. - Product / Service
o Exhibit 164: Walvax Biotechnology Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 165: Inclusions checklist
o Exhibit 166: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 167: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 168: Research methodology
o Exhibit 169: Validation techniques employed for market sizing
o Exhibit 170: Information sources
o 13.5 List of abbreviations
o Exhibit 171: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global pneumococcal vaccine market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Government authorities - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Government authorities - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Government authorities - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Government authorities - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Distribution partner companies - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Distribution partner companies - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Astellas Pharma Inc. - Overview
Exhibits112: Astellas Pharma Inc. - Product / Service
Exhibits113: Astellas Pharma Inc. - Key news
Exhibits114: Astellas Pharma Inc. - Key offerings
Exhibits115: Biological E. Ltd. - Overview
Exhibits116: Biological E. Ltd. - Product / Service
Exhibits117: Biological E. Ltd. - Key offerings
Exhibits118: CSL Ltd. - Overview
Exhibits119: CSL Ltd. - Business segments
Exhibits120: CSL Ltd. - Key offerings
Exhibits121: CSL Ltd. - Segment focus
Exhibits122: GlaxoSmithKline Plc - Overview
Exhibits123: GlaxoSmithKline Plc - Business segments
Exhibits124: GlaxoSmithKline Plc - Key news
Exhibits125: GlaxoSmithKline Plc - Key offerings
Exhibits126: GlaxoSmithKline Plc - Segment focus
Exhibits127: Merck and Co. Inc. - Overview
Exhibits128: Merck and Co. Inc. - Business segments
Exhibits129: Merck and Co. Inc. - Key news
Exhibits130: Merck and Co. Inc. - Key offerings
Exhibits131: Merck and Co. Inc. - Segment focus
Exhibits132: Panacea Biotec Ltd. - Overview
Exhibits133: Panacea Biotec Ltd. - Product / Service
Exhibits134: Panacea Biotec Ltd. - Key offerings
Exhibits135: Petrovax - Overview
Exhibits136: Petrovax - Product / Service
Exhibits137: Petrovax - Key offerings
Exhibits138: Pfizer Inc. - Overview
Exhibits139: Pfizer Inc. - Product / Service
Exhibits140: Pfizer Inc. - Key news
Exhibits141: Pfizer Inc. - Key offerings
Exhibits142: Sanofi - Overview
Exhibits143: Sanofi - Business segments
Exhibits144: Sanofi - Key news
Exhibits145: Sanofi - Key offerings
Exhibits146: Sanofi - Segment focus
Exhibits147: Serum Institute of India Pvt. Ltd. - Overview
Exhibits148: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits149: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits150: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibits151: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
Exhibits152: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibits153: Sinovac Biotech Ltd. - Overview
Exhibits154: Sinovac Biotech Ltd. - Product / Service
Exhibits155: Sinovac Biotech Ltd. - Key offerings
Exhibits156: SK Inc. - Overview
Exhibits157: SK Inc. - Product / Service
Exhibits158: SK Inc. - Key offerings
Exhibits159: Vaxcyte Inc. - Overview
Exhibits160: Vaxcyte Inc. - Product / Service
Exhibits161: Vaxcyte Inc. - Key offerings
Exhibits162: Walvax Biotechnology Co. Ltd. - Overview
Exhibits163: Walvax Biotechnology Co. Ltd. - Product / Service
Exhibits164: Walvax Biotechnology Co. Ltd. - Key offerings
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations